Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Retail - Pharmacy. Per the activity note to the FY2021 annual report, the company carries out retail and wholesale trade in pharmaceutical products and personal hygiene items.
Group parent — controls 1 company · ownership
| Ratio | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 29.3% | 28.8% | 27.1% | 27.4% |
| EBITDA Margin | 11.2% | 10.2% | 10.6% | 3.7% |
| EBITDAR | 1,540 | 1,669 | 2,156 | 1,324 |
| EBITDAR Margin | 14.8% | 13.5% | 14.0% | 8.8% |
| EBIT Margin | 10.7% | 9.7% | 10.2% | 3.2% |
| Net Profit Margin | 9.9% | 9.8% | 9.6% | 3.3% |
| Operating Expense % of Sales | 18.1% | 18.6% | 16.5% | 23.8% |
| Returns | ||||
| Return on Assets (ROA) | 21.7% | 24.3% | 19.1% | 6.3% |
| Return on Equity (ROE) | 26.7% | 29.1% | 30.6% | 10.1% |
| ROIC [EBIT / Invested Capital] | 34.1% | 35.0% | 53.5% | 12.8% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 81.3% | 83.5% | 62.6% | 62.0% |
| Net Debt | -570 | -715 | -1,883 | -1,116 |
| Cash & Equivalents | 570 | 715 | 1,883 | 1,116 |
| Total Debt | N/A | N/A | N/A | N/A |
| Liquidity & working capital | ||||
| Current Ratio | 4.23x | 491.36x | 2.39x | 2.25x |
| Quick Ratio | 4.27x | 488.00x | 1.35x | 1.20x |
| Cash Ratio | 0.65x | 0.87x | 0.65x | 0.38x |
| Total Current Assets | 3,719 | 403,925 | 6,877 | 6,695 |
| Total Current Liabilities | 878 | 822 | 2,879 | 2,976 |
| Inventory | -32 | 2,761 | 3,002 | 3,114 |
| Trade Receivables | 491 | 451 | 1,717 | 1,887 |
| Trade Payables | 781 | 757 | 2,832 | 2,936 |
| Net Working Capital | 2,841 | 403,103 | 3,998 | 3,719 |
| Net Working Capital % of Revenue | 27.3% | 3268.6% | 26.0% | 24.8% |
| Trade Working Capital | -322 | 2,455 | 1,888 | 2,065 |
| Trade Working Capital % of Revenue | -3.1% | 19.9% | 12.3% | 13.8% |
| Change in Trade Working Capital | N/A | 2,777 | -568 | 177 |
| Turnover & efficiency | ||||
| Inventory Turnover | -230.41x | 3.18x | 3.74x | 3.49x |
| Days Inventory Outstanding (DIO) | -1.6 | 114.8 | 97.6 | 104.4 |
| Receivables Turnover | 21.18x | 27.32x | 8.97x | 7.95x |
| Days Sales Outstanding (DSO) | 17.2 | 13.4 | 40.7 | 45.9 |
| Payables Turnover | 9.41x | 11.59x | 3.96x | 3.71x |
| Days Payable Outstanding (DPO) | 38.8 | 31.5 | 92.1 | 98.5 |
| Cash Conversion Cycle | -23.1 days | 96.7 days | 46.2 days | 51.9 days |
| Asset Turnover | 2.21x | 2.48x | 2.00x | 1.91x |
| Cash flow & dividends | ||||
| Operating Cash Flow | 501 | 1,074 | 1,795 | 81 |
| Free Cash Flow (OCF − Capex proxy) | 410 | 1,063 | 1,746 | -299 |
| Cash Conversion (OCF / EBITDA) | 43.2% | 85.3% | 110.4% | 14.7% |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →